Arimidex 1 mg Tablets

Arimidex (Anastrozole) 1mg Tablets is a medication used to treat breast cancer in women. Here are some key points about the product:

Composition:

Arimidex 1mg Tablets contains anastrozole, a non-steroidal aromatase inhibitor that reduces the production of estrogen in the body.

Indications:

Arimidex 1mg Tablets is indicated for the treatment of:

1. Hormone-receptor-positive breast cancer in postmenopausal women
2. Adjuvant treatment of hormone-receptor-positive breast cancer in postmenopausal women
3. Advanced breast cancer in postmenopausal women who have received prior therapy

Mechanism of Action:

Anastrozole 1mg Tablets works by:

1. Inhibiting the activity of aromatase, an enzyme that converts androgens into estrogens
2. Reducing the production of estrogen, which can stimulate the growth of breast cancer cells

Dosage and Administration:

The recommended dosage of Arimidex 1mg Tablets is:

• 1mg taken orally once daily, with or without food
• Take at the same time each day

Side Effects:

Common side effects of Arimidex 1mg Tablets include:

1. Hot flashes
2. Fatigue
3. Headache
4. Dizziness
5. Nausea
6. Vomiting
7. Abdominal pain

Serious side effects can include:

1. Liver damage
2. Bone fractures
3. Cardiovascular disease
4. Hematological toxicity (e.g., anemia, neutropenia)

Contraindications:

Arimidex 1mg Tablets is contraindicated in patients with:

1. Hypersensitivity to anastrozole
2. Pregnancy or breastfeeding
3. Severe hepatic impairment (Child-Pugh C)

Precautions:

1. Patients with a history of liver disease or liver damage should be closely monitored while receiving Arimidex 1mg Tablets.
2. Patients with a history of cardiovascular disease or cardiovascular risk factors should be closely monitored while receiving Arimidex 1mg Tablets.

Patient Counseling:

• Patients should be counseled on the importance of taking their medication as directed and not missing doses.
• Patients should be instructed to report any signs of hot flashes, fatigue, or abdominal pain.
• Patients should be advised to report any changes in their menstrual cycle or symptoms of bone loss.

Storage and Handling:

• Store bottles at room temperature between 15°C and 30°C (59°F and 86°F).
• Do not expose to direct sunlight or moisture.
• Use within 24 hours of opening.

Please note that the dosage and administration information is based on the recommended dosage and may vary depending on individual patient needs and circumstances.